ArticleScientific reports2026
Multifunctional bioactivity of Portulaca oleracea seed oil: GC-MS-based characterization and in vitro evaluation.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purslane (Portulaca oleracea L.) is a widespread weed highly valued for its nutritional value, particularly its omega-3 fatty acid content. This study aimed to investigate the pharmacological properties and the phenolic and flavonoid contents of P. olecracea seed oil. P. oleracea seed oil was tested for antioxidant activity (DPPH· and ABTS), cell viability and cytotoxicity and anti-inflammatory activity. The contents of total phenolics, flavonoids, and constituents were characterized. The seed oil of P.oleracea had high flavonoid (4.53 mg/g) and phenolic (8.65 mg/g) content. The antioxidant activity of P. oleracea seed oil increased from 24.16% at a concentration of 0.5 µg/mL to 97.28% at a concentration of 1000 µg/mL. The MTT assay demonstrated that P. oleracea seed oil exhibited relatively weak to moderate cytotoxic activity against the A549, HepG-2, and MCF-7 cell lines. Lower concentrations of the seed oil extract exhibited anti-inflammatory activity, and these effects were compared with those of indomethacin as a positive control. GC-MS analysis showed that the seed oil of P. oleracea is rich in olean-12-ene-3,28-diol and 9-octadecenoic acid. It could be concluded that P. oleracea seed oil exhibits notable in vitro antioxidant and cytotoxic activities, which may be attributed to its content of flavonoids and phenolic compounds. However, further in vivo studies and toxicity evaluations are required to confirm its potential applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.